MIRA Pharmaceuticals, Inc. – NASDAQ:MIRA
MIRA Pharmaceuticals stock price today
MIRA Pharmaceuticals stock price monthly change
MIRA Pharmaceuticals stock price quarterly change
MIRA Pharmaceuticals stock price yearly change
MIRA Pharmaceuticals key metrics
Market Cap | 17.47M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.80 |
Revenue | N/A |
EBITDA | -8.95M |
Income | -12.35M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMIRA Pharmaceuticals stock price history
MIRA Pharmaceuticals stock forecast
MIRA Pharmaceuticals financial statements
| Jun 2023 | 0 | -1.26M | |
|---|---|---|---|
| Sep 2023 | 0 | -3.58M | |
| Dec 2023 | 0 | -5.78M | |
| Mar 2024 | 0 | -1.71M |
| Sep 2025 | 0 | -886.85K | |
|---|---|---|---|
| Oct 2025 | 0 | -1.57M | |
| Dec 2025 | 0 | -1.09M | |
| Dec 2025 | 0 | -1.87M |
Analysts Price target
Financials & Ratios estimates
| 2024-05-13 | -0.1 | -0.12 |
|---|
| Jun 2023 | 3825136 | 2.62M | 68.72% |
|---|---|---|---|
| Sep 2023 | 9018212 | 902.90K | 10.01% |
| Dec 2023 | 4932443 | 558.09K | 11.31% |
| Mar 2024 | 3808791 | 652.00K | 17.12% |
| Jun 2023 | -660.81K | 0 | 684.28K |
|---|---|---|---|
| Sep 2023 | -1.76M | 0 | 7.60M |
| Dec 2023 | -2.13M | 0 | 869.34K |
| Mar 2024 | -1.04M | 0 | -24.33K |
MIRA Pharmaceuticals alternative data
| Sep 2023 | 2 |
|---|---|
| Oct 2023 | 2 |
| Nov 2023 | 2 |
| Dec 2023 | 2 |
| Jan 2024 | 2 |
| Feb 2024 | 2 |
| Mar 2024 | 2 |
| Apr 2024 | 2 |
| May 2024 | 2 |
| Jun 2024 | 2 |
| Jul 2024 | 2 |
MIRA Pharmaceuticals other data
| Period | Buy | Sel |
|---|---|---|
| May 2024 | 8700 | 0 |
| Aug 2024 | 0 | 200000 |
| Nov 2024 | 0 | 100000 |
-
What's the price of MIRA Pharmaceuticals stock today?
One share of MIRA Pharmaceuticals stock can currently be purchased for approximately $1.41.
-
When is MIRA Pharmaceuticals's next earnings date?
Unfortunately, MIRA Pharmaceuticals's (MIRA) next earnings date is currently unknown.
-
Does MIRA Pharmaceuticals pay dividends?
No, MIRA Pharmaceuticals does not pay dividends.
-
How much money does MIRA Pharmaceuticals make?
MIRA Pharmaceuticals has a market capitalization of 17.47M. MIRA Pharmaceuticals made a loss 11.98M US dollars in net income (profit) last year or -$0.12 on an earnings per share basis.
-
What is MIRA Pharmaceuticals's stock symbol?
MIRA Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "MIRA".
-
What is MIRA Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - General industry.
-
How do i buy shares of MIRA Pharmaceuticals?
Shares of MIRA Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does MIRA Pharmaceuticals have?
As Jul 2024, MIRA Pharmaceuticals employs 2 workers.
-
When MIRA Pharmaceuticals went public?
MIRA Pharmaceuticals, Inc. is publicly traded company for more then 2 years since IPO on 14 Aug 2023.
-
What is MIRA Pharmaceuticals's official website?
The official website for MIRA Pharmaceuticals is mirapharmaceuticals.com.
-
Where are MIRA Pharmaceuticals's headquarters?
MIRA Pharmaceuticals is headquartered at 855 North Wolfe Street, Baltimore, MD.
-
How can i contact MIRA Pharmaceuticals?
MIRA Pharmaceuticals's mailing address is 855 North Wolfe Street, Baltimore, MD and company can be reached via phone at +7 372890835.
MIRA Pharmaceuticals company profile:
MIRA Pharmaceuticals, Inc.
mirapharmaceuticals.comNASDAQ
2
Drug Manufacturers - General
Healthcare
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Baltimore, MD 21205
CIK: 0001904286
ISIN: US60458C1045
CUSIP: 60458C104
